Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medec Medicare Limited, formerly known as Medec Dragon, is a rapidly growing pharmaceutical company based in Mumbai, India, that specializes in the research, development, and contract manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company operates an asset-light business model, leveraging strategic partnerships with WHO-GMP certified manufacturing facilities to supply high-quality products to over 70 countries worldwide. Medec Medicare focuses on critical therapeutic segments including oncology, cardiovascular health, diabetes management, and infectious diseases. With a robust portfolio of over 25 advanced intermediates and 14 registered process patents, the company serves as a preferred partner for both innovator and generic pharmaceutical firms globally. Medec Medicare is recognized for its commitment to green chemistry and sustainable manufacturing practices, recently receiving accolades for corporate governance and leadership in the Indian pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEDEC.